2012 WPPF/FIP Travel Scholarship Winners are Announced!

                  2012 WPPF/FIP Travel Scholarship Winners are Announced!



The President, John Ware, and members of the Executive of the Western Pacific Region Pharmaceutical Forum announced that the WPPF/FIP Travel Scholarships to the FIP Congress in Amsterdam,Netherland have been awarded to Mr.PAUL MARVIN T.QUIZON (Philippines) and Mr.SHANEEL KUMAR (Fiji).


The Forum was delighted and believed that the awardees would have a great influence in supporting the development of modern pharmacy practice and education in their own countries. The Forum congratulated the two awardees and hoped that those candidates who were not successful will consider applying again next year for the FIP Congress.


The President also expressed his great delight to the awardees and hoped the contacts they make in Amsterdam would give them great confidence in moving forward in their vision for good pharmacy practice and education in their countries.


The following attachments are statements from the two scholarship winners.

Or please take a look to our Scholarship Section for more information.Thank you

                              1.Mr.PAUL MARVIN T.QUIZON (Philippines)                                                                                    2.Mr.SHANEEL KUMAR (Fiji).

Quick Take (03/25/12)

Main News:

1.2012 WPPF/FIP Travel Scholarship Winners are Announced!

2.WHO-More evidence and better diagnostics needed before redefining severe forms of drug-resistant TB 

3.WHO-Childhood Tuberculosis Neglected, Despite Available Remedie

4.International Meeting of World Pharmacopoeias

News Update:

1.Community Pharmacies Put Patients First

2.Majority in favour of removing Pharmacists From SOL

3.PGA Newsletter – Vol.2 No.9 14th Mar.,2012

4.PGA Newsletter – Vol.2 No.10 21st Mar.,2012

5.New Era in Pharmacy Professional Development and Practice Support

6.Consultation on Advanced Pharmacy Practice

7.Advanced Pharmacy Practice A Consultation Paper for the Pharmacy Profession

8.PSS-106th Annual General Meeting

9.Centers for Disease Control strict controls on the payment for HAART

10.A Small Talk about PTSD

11.ReAct Participating in WHO Launch of Book on Successful Strategies


Pharmacy Education- E- Learning:

1.NPS-Recommendations for the 2012 Influenza Season

International New:

1.WHO-Childhood Tuberculosis Neglected, Despite Available Remedies

2.WHO More Evidence and Better Diagnostics Needed Before Redefining Severe forms of Drug-Resistant TB says WHO

3.International Meeting of World Pharmacopoeias


1.WHO-Safety Monitoring of Medicinal Products

Upcoming Event Calendar:

1.Pharmacy Practice Scientific Conference(03/23/12-03/28/12)

2.World Health Day(04/07/12)

3.First European Conference on Patient Empowerment (04/11/12-04/12/12)

Childhood Tuberculosis Neglected, Despite Available Remedie

Childhood TB is a hidden epidemic

21 MARCH 2012 | GENEVA – Tuberculosis (TB) often goes undiagnosed in children from birth to 15 years old because they lack access to health services – or because the health workers who care for them are unprepared to recognize the signs and symptoms of TB in this age group. With better training and harmonization of the different programmes that provide health services for children, serious illness and death from TB could be prevented in thousands of children every year, WHO and Stop TB Partnership said today.

Childhood TB a hidden epidemic

“We have made progress on TB: death rates are down 40% overall compared to 1990 and millions of lives have been saved,” said Dr Mario Raviglione, Director of the WHO Stop TB Department. “But unfortunately, to a large extent, children have been left behind, and childhood TB remains a hidden epidemic in most countries. It is time to act and address it everywhere”.

Most families who are vulnerable to TB live in poverty and know little about the disease and how to obtain care for it. All too often, when an adult is diagnosed with TB, no attempt is made to find out whether children in the household also have the disease. This is a crucial step, since most children catch TB from a parent or relative. Any child living with a TB patient and that has an unexplained fever and failure to thrive may have the disease and should be evaluated by a health worker for TB. Those who are not ill with TB should be protected against the disease through preventive therapy with the drug isoniazid. Those who are ill should receive treatment.

Read more, please click:

Childhood Tuberculosis Neglected, Despite Available Remedie

More Evidence and Better Diagnostics Needed Before Redefining Severe Forms of Drug-Resistant TB

23 MARCH 2012 | GENEVA – Reports of tuberculosis (TB) cases with severe patterns of drug resistance are increasing, said experts who attended a WHO meeting in Geneva on 21-22 March. Participants stressed that the emergence of drug resistance should be a wake-up call for Ministries of Health. The group urged the global TB community to make greater efforts to prevent drug resistance and scale up provision of appropriate care and management to avoid a scenario where TB becomes incurable.

Insufficient evidence

The meeting concluded that there is currently insufficient evidence to adopt new case definitions for drug-resistant TB. Drug susceptibility testing (DST), which is key to defining new levels of drug resistance, lacks accuracy for several of the drugs that are used to treat multi drug-resistant (MDR) and extensively drug resistant (XDR)-TB. Secondly, there is insufficient correlation of DST results with clinical response to treatment for several drugs currently used to treat XDR-TB. Thirdly, new drugs are currently undergoing clinical trials, and could prove effective against drug resistant strains. The meeting urged diagnostics companies and TB laboratories to develop better diagnostic tests and also agreed that WHO and technical partners should develop more detailed guidance on XDR-TB treatment.

Read more, please click:

More Evidence and Better Diagnostics Needed Before Redefining Severe Forms of Drug-Resistant TB

ReAct Participating in WHO Launch of Book on Successful Strategies


The book, The evolving threat of antimicrobial resistance – Options for action, launched by WHO on March 8, is the result of a collaboration between WHO and more than 50 international experts in the field of antimicrobial resistance where ReAct contributed with working group leaders and main authors of two of the chapters.

For more information, please refer to publication or ReAct Website:

WHOThe Evolving Threat of Antimicrobial Resistance: Options For Action

ReAct: watch the ReAct video presentation on reactgroup.org/news

A small talk about PTSD

A small talk about PTSD

Article/ Lu Lingyu (Pharmacist of Taoyuan mental Hospital, Department of Health)


Article/ Lu Lingyu (Pharmacist from Taoyuan mental Hospital,Department of Health)

Translator:Liu TingYi

After watching the Japanese drama “Team Medical Dragon 3”, except the importance of “team work” which was constantly emphasized in the drama, another impressive picture was Dr. Sakaguchi Kenji couldn’t wield the surgical knife in the latter segment because PTSD. What is PTSD? Will it probably happened to everyone or is it a serious illness?

PSTD’s full name is Posttraumatic Stress Disorder, and it’s a kind of disorder related to stress events. It usually results from people experienced some serious incidents, for example the serious body injuries result in the psychological trauma, or are forced to confront one or multiple events which had the severely threat of bodily integrity to oneself or to someone else and so on. And these traumatic matters were re-experienced by one or multiple ways that are usually as painful processes no matter it is physical or mental. Sometimes, people will once again feel the unhappy picture at that time in the dream, and this situation always let people descend into the abyss and cannot extricate themselves. They will hold the evaded state of mind for those might let them remember the trauma, and they might gradually show the reaction of excessive anxiety, insomnia and excessive startle and so on.

PTSD can occur at any age, therefore, even the young children are possibly developing PTSD. However, because of the children cannot clearly express their innermost thoughts like adults, the diagnosis will be different between child and adult. Symptoms usually begin within three months of the incident, and the duration for more than one month. In therapy that will usually treat anti-depressants in primary cure, such as selective serotonin reuptake inhibitor (Fluoxetine, Paroxetine, sertraline and fluvoxamine) and monoamine oxidase inhibitors are used for treating PTSD patients. Other medicines like Carbamazepine, Valproic acid, Beta-blocker and Lithium are also involved.

PTSD patients usually need to stand on their own and receive the assistance from families, which will help them go out of the haze. After the appropriate treatment and a period of comprehension, the patients will raise the traumatic experiences to the valuable experiences of growth. With the proper adjustment and believe there are still hopes that will colorful their life.

Centers for Disease Control strict controls on the payment for HAART

Centers for Disease Control strict controls on the payment for HAART

                               -Pharmacists shall assist to check

Reporter/Taitung County Wang Chung-jen


Reporter/Taitung County Wang Chung-jen

Translator:Liu TingYi

Our country is one of the few countries first provide HIV infectors with Highly Active Anti-Retroviral Therapy (HARRT) for free in the world at present. Since 1997 provides free HARRT, the lethality rates for AIDS cases have declined year by year. Forty-five designated hospitals in Taiwan provide those infectors with free medical therapy that caused the accessibility of medical care improved for the infectors.

However, the free supply of HARRT results in huge increasing in drug expenditure, and the average medical expenses for each infector is about three hundred and fifty thousand dollars per year. Because of the decline in mortality rates and the increment in survival rates, number of the infected persons has been increased and medical expenses/drug expenditure also augmented, which has been confronted by the plight of a serious shortage of the public affairsbudget of the government.

According to article fifth of “Regulations on Expense payment for Human Immunodeficiency Virus (HIV) inspection, prevention and treatment”, the designated medical institution can apply for the expense payment items are as below:

1. The medical expense for the relative treatment of HIV outpatient and hospital costs by diagnosis.

2. Drug charge for HIV.

3. Dispensing service fees for HIV medicines.

4. Inspection fees for HIV-1 viral load examination and lymphocyte subset analysis (infectious disease).

5. Other items specified by the central competent authority.

The payment benchmark for the preceding expense payment items is as below:

1. The items and prices of payment which set by central competent authority.

2. The payment standard of medical expense by National Health Insurance.

3. The items and prices of medicines and special materials which enclosed by National Health Insurance.

The anti-HIV medicines in the regulation of item 2, paragraph 1 has mentioned the usage regulation shall follow the regulation by central competent authority.
Therefore, in accordance with the payment benchmark in “Regulations on Expense payment for Human Immunodeficiency Virus (HIV) inspection, prevention and treatment”, the Centers for Disease Control has been set the newest payment regulation. And they decide to announce three implemented policy in March of the following, which provide the HARRT prescription for reviewing reference for pharmacists in the future.

1. The regulation of prescription: for all patients who need the prescription of anti-HIV, the prescription with same efficiency and lower prices has priority (the charges for medicine lower than twenty thousands and five hundred dollars per month).

2. To take the system of prior examination: if use the prescription which exceeds the limited amount of the charges for medicine per month, the prescription shall submit an application for prior examination.

3. To strengthen the random examination execution for the anamnesis: if use the prescription which exceeds the limited amount of the charges for medicine per month, the anamnesis shall mark the reason and strengthen the random examination. And pharmacists shall inform the hospital if the prescription is irregularity or unreasonable. The hospital shall not pay the case for the prescription after receiving the inform next month.

Anyway, health units of government have been adopted the necessary measure on the payment of anti-AIDS treatment. Therefore, pharmacists shall act as keepers on prescription examination, and assist the government to control the improper payment of medicine expense to avoid the medical resources waste and save the social resources.

PSS-106th Annual General Meeting

The 106th Annual General Meeting was held in York Hotel on 17-Mar-2012 in conjunction with the Pre-reg Graduation ceremony and with a side event showcasing the  talents of our fellow pharmacists in a fun-filled event coined Pharmacist Got Talent.


For more information, please click:

PSS-106th Annual General Meeting

Advanced Pharmacy Practice A Consultation Paper for the Pharmacy Profession

March 2012
Background and purpose
It is important that this initiative directed at defining and recognising advanced pharmacy practice has input 
from and the support of the profession.  This Consultation Paper has been prepared through the Advanced  Pharmacy Practice Framework Steering Committee (APPFSC) on behalf of the pharmacy organisations whose logos appear below.  It was prepared for consultation within the pharmacy profession and is intended as a means to seek support of the profession and stimulate debate and feedback that will improve its content.
The work being undertaken by the APPFSC is intended to be one activity that may help to inform further development of the profession and of the professional roles performed.  The APPFSC is committed to pursuing formal recognition for those pharmacists demonstrated to be working at an advanced practice level and it is hoped this work will underpin efforts to gain that recognition.
Following an eight-week consultation period, the APPFSC will meet to discuss comments and submissions received with a view to creating a final draft document.
The final draft document will be provided to Steering Committee Members to seek comment and endorsement by the board of their respective organisations.  The document will then be finalised by the APPFSC on behalf of the pharmacy profession and submitted to the Pharmacy Board of Australia for consideration.
Written submissions are invited from members of the pharmacy profession.  Twelve Consultation issues are listed in the document but comment is welcomed on any matter contained in the Paper.
Written submissions marked ‘Advanced Pharmacy Practice Consultation’ may be:
– posted to PO Box 42, Deakin West, ACT 2600; or
Submissions must be received by close of business on 15 May 2012 to be considered in this 
consultation process.
A background document used to develop this Consultation Paper and containing additional detail of:
– the mapping of the CoDEG framework to the Australian national competency framework; and
– example application of the APPF to another practice area (Management and Administration);is available on request by email (only).  Please send an email to APPconsultation@psa.org.au with the Subject line “APP Background paper requested”.
For more information, please click:

Consultation on Advanced Pharmacy Practice

19th Mar.,2012
The Advanced Pharmacy Practice Framework Steering Committee (APPFSC) is a profession-wide collaborative forum, working on initiatives which are linked to the national competency standards for pharmacists.
The APPFSC, chaired by Dr Shane Jackson, is pleased to release a Consultation Paper on Advanced Pharmacy Practice and invite members of the pharmacy profession to provide comment.
The Paper outlines a generic advanced pharmacy practice framework (APPF) in ‘Patient Care’ which has flexibility to be adapted to other areas of practice, for example,‘Management and Administration’.The generic APPF is linked to the profession’s competency standards and is intended to be a tool to support the professional development and growth of pharmacists in Australia.
For more information, please click: